Chromosome engineering in zygotes with CRISPR/Cas9

被引:64
|
作者
Boroviak, Katharina [1 ]
Doe, Brendan [1 ]
Banerjee, Ruby [1 ]
Yang, Fengtang [1 ]
Bradley, Allan [1 ]
机构
[1] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England
基金
英国惠康基金;
关键词
CRISPR; Cas9; large structural variants; zygote injection; ONE-STEP GENERATION; MOUSE MODEL; MICE; GENE; INVERSIONS; DELETIONS; RECOMBINATION; ZEBRAFISH; SYSTEM; CELLS;
D O I
10.1002/dvg.22915
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Deletions, duplications, and inversions of large genomic regions covering several genes are an important class of disease causing variants in humans. Modeling these structural variants in mice requires multistep processes in ES cells, which has limited their availability. Mutant mice containing small insertions, deletions, and single nucleotide polymorphisms can be reliably generated using CRISPR/Cas9 directly in mouse zygotes. Large structural variants can be generated using CRISPR/Cas9 in ES cells, but it has not been possible to generate these directly in zygotes. We now demonstrate the direct generation of deletions, duplications and inversions of up to one million base pairs by zygote injection. genesis 54:78-85, 2016. (c) 2016 The Authors. Genesis Published by Wiley Periodicals, Inc.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [31] Germline engineering of the chicken genome using CRISPR/Cas9 byin vivotransfection of PGCs
    Challagulla, Arjun
    Jenkins, Kristie A.
    O'Neil, Terri E.
    Morris, Kirsten R.
    Wise, Terry G.
    Tizard, Mark L.
    Bean, Andrew G. D.
    Schat, Karel A.
    Doran, Timothy J.
    ANIMAL BIOTECHNOLOGY, 2023, 34 (04) : 775 - 784
  • [32] CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects
    Kaligotla, Venkata Subrahmanya Anirudh
    Jasti, Tejaswi
    Kandra, Prameela
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2022, 69 (03) : 1238 - 1251
  • [33] Advances in CRISPR/Cas9 Genome Editing for the Treatment of Muscular Dystrophies
    Fatehi, Sina
    Marks, Ryan M.
    Rok, Matthew J.
    Perillat, Lucie
    Ivakine, Evgueni A.
    Cohn, Ronald D.
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 388 - 403
  • [34] Application of CRISPR/Cas9 in Alzheimer's Disease
    Lu, Likui
    Yu, Xi
    Cai, Yongle
    Sun, Miao
    Yang, Hao
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [35] Repurposing CRISPR/Cas9 for in situ functional assays
    Malina, Abba
    Mills, John R.
    Cencic, Regina
    Yan, Yifei
    Fraser, James
    Schippers, Laura M.
    Paquet, Marilene
    Dostie, Josee
    Pelletier, Jerry
    GENES & DEVELOPMENT, 2013, 27 (23) : 2602 - 2614
  • [36] Application of the CRISPR/Cas9 system in Dioscorea zingiberensis
    Feng, Shan
    Song, Wei
    Fu, Ruirui
    Zhang, Hong
    Xu, Anran
    Li, Jiaru
    PLANT CELL TISSUE AND ORGAN CULTURE, 2018, 135 (01) : 133 - 141
  • [37] CRISPR/Cas9: Development and Application in Rice Breeding
    Romero, Fernando Matias
    Gatica-Arias, Andres
    RICE SCIENCE, 2019, 26 (05) : 265 - 281
  • [38] CRISPR/Cas9 for Human Genome Engineering and Disease Research
    Xiong, Xin
    Chen, Meng
    Lim, Wendell A.
    Zhao, Dehua
    Qi, Lei S.
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 17, 2016, 17 : 131 - 154
  • [39] CRISPR/Cas9 Immune System as a Tool for Genome Engineering
    Hryhorowicz, Magdalena
    Lipianki, Daniel
    Zeyland, Joanna
    Slomski, Ryszard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2017, 65 (03) : 233 - 240
  • [40] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888